The aim of this post-market confirmatory interventional clinical investigation is to evaluate the performance and safety of AI500™ SINGLE-DOSE GEL in patients with reduced knee function.
Evaluation of the effect of the AI500™ SINGLE-DOSE GEL medical device in patients with reduced knee function